Symposia
Promoting innovation through
knowledge transfer
In order to maximize the impact of research and promote innovation, BQC19 organizes knowledge transfer activities and symposiums. These initiatives aim to share scientific advances with clinical and academic communities, stimulate interdisciplinary exchanges, and encourage the adoption of new evidence-based practices. They also build bridges between researchers, decision-makers, and users, thereby strengthening the scope and relevance of the work supported.
Keep an eye on
The 5th BQC19 symposium will take place on September 17, 2025, at the Sainte-Justine University Hospital Center.
Details will be available soon.
Visit the News page to learn more.
4th BQC19 Symposium
A springboard for collective research
February 20, 2024, Amphitheater of the CHUM Research Center
2nd BQC19 Symposium
BQC19: A key infrastructure for COVID-19 research from childhood to adulthood
November 29, 2022, McGill University Health Centre Research Institute and via videoconference
As with the first edition, the forum’s objective is to promote research conducted using BQC19 data and samples. The forum will present the characteristics of BQC19 (participant profiles, data and samples collected, examples of analyses). For this second edition, the focus will be on pediatric and adult cohorts, as well as opportunities to support research on post-COVID conditions (long COVID) using BQC19.
Among the presenters, Vincent Mooser, founding director of BQC19 (2020-22), will address participants during a plenary session, and David Bujold will present the new data visualization and querying tool developed to facilitate the development of studies based on the BQC19 collection.
There will be a 60-minute session to share experiences and ask questions in a friendly format.
Clinical and molecular determinants of COVID-19: Research using data and samples from the BQC19
May 10, 2022, Symposium presented at the 89th ACFAS conference held at Laval University
Even though the COVID-19 pandemic is losing momentum, many scientific questions remain, and research on this disease remains more essential than ever, particularly on the clinical and molecular determinants of susceptibility, severity, and consequences of COVID-19. More recently, new avenues of research have emerged, such as vaccine efficacy in the context of evolving variants, the persistence of vaccine protection, the impact on at-risk populations, and the evolution and repercussions of post-COVID-19 disease or the pandemic on the pediatric population. The Quebec COVID-19 Biobank (BQC19), a research infrastructure created in March 2020 in the context of the health emergency, is well positioned to provide the scientific community and public health decision-makers with high-quality data and samples to answer these questions.
We would like to express our gratitude to the researchers who agreed to present their results, as well as to the BQC19’s funding agencies: the Fonds de recherche du Québec – Santé, the Public Health Agency of Canada, and Génome Québec.
1st BQC19 Symposium
The Quebec COVID-19 Biobank (BQC19) celebrates its first year of operations!
April 20, 2021, via videoconference
